Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell “missing self” recognition
Immunogenetics · 2017-08 · 69 (8-9) · 547-556
DOI: 10.1007/s00251-017-1011-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunogenetics, online erschienen am 11.07.2017. Verfasst von Karl-Johan Malmberg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. k.j.malmberg@medisin.uio.no. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Kreftforeningen, Cancerfonden.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. k.j.malmberg@medisin.uio.no.
- The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. k.j.malmberg@medisin.uio.no.
- Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. k.j.malmberg@medisin.uio.no.
- Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
- The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Förderung
- Vetenskapsrådet
- Kreftforeningen
- Cancerfonden
- Helse Sør-Øst RHF
- Barncancerfonden
Zitieren
APA
Malmberg, K. J., Sohlberg, E., Goodridge, J. P., & Ljunggren, H. G. (2017). Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell “missing self” recognition. Immunogenetics, 69(8-9), 547-556. https://doi.org/10.1007/s00251-017-1011-9
Vancouver
Malmberg KJ, Sohlberg E, Goodridge JP, Ljunggren HG. Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell “missing self” recognition. Immunogenetics. 2017;69(8-9):547-556. doi:10.1007/s00251-017-1011-9
BibTeX
@article{Malmberg2017,
author = {Malmberg, Karl-Johan and Sohlberg, Ebba and Goodridge, Jodie P and Ljunggren, Hans-Gustaf},
title = {Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell “missing self” recognition},
journal = {Immunogenetics},
year = {2017},
volume = {69},
number = {8-9},
pages = {547--556},
doi = {10.1007/s00251-017-1011-9}
}
EUVIMED